Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
4 hedge funds and large institutions have $39K invested in Vaxart in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.
14% more capital invested
Capital invested by funds: $34.2K → $39K (+$4.82K)
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
+$6.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GSEP
Golden State Equity Partners
South Coast Metro,
California
|
-$1.21K |
| 2 |
FCAS
First Command Advisory Services
Fort Worth,
Texas
|
-$24 |
VXRT Hedge Fund Activity: Q2 2026 in Review
4 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2026, worth a combined $39K — up 14% from $34.2K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of VXRT and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was Kingswood Wealth Advisors, opening a new position worth an estimated $6.05K. The largest seller was Golden State Equity Partners, exiting entirely with an estimated $1.21K sold.
- 4 institutional investors held Vaxart (VXRT) as of Q2 2026, down from 5 in Q1 2026.
- Funds reported $39K of Vaxart stock for Q2 2026, up 14% quarter-over-quarter.
- 1 fund opened new Vaxart positions in Q2 2026 and 2 closed out, a net change of -1 holder.
- The largest Vaxart buyer in Q2 2026 was Kingswood Wealth Advisors, an estimated $6.05K added.
- The largest Vaxart seller in Q2 2026 was Golden State Equity Partners, an estimated $1.21K sold.
Based on aggregated 13F filings for Q2 2026.